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Abstract
Objectives: The objective of this study was to identify the role of reactive oxygen species (ROS) generated by
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, in inositol hexaphosphate (IP6)-induced metabolic
disruption in human leukemia PLB-985 cells.
Methods: PLB-985 and X chromosome linked gp91-phox gene knockout (X-CGD) cells were treated with 5, 10, or
20 mM IP6 for 24 to 72 h. Cell growth was assayed using a highly water-soluble tetrazolium salt. The rate of
apoptotic and necrotic cell death was determined with an Annexin V-fluorescein isothiocyanate/propidium iodide kit.
The expression of CD11b as a marker of monocytic property and of LC3 as an autophagy marker was tested, using
flow cytometry combined with fluorescent antibodies.
Results: Treatment with 5 and 10 mM IP6 for 24 h was found to suppress the growth of both cell lines, though the
effect was more dramatic in PLB-985 cells. After 6-h treatment with 20 mM IP6, the necrosis rate of PLB-985 cells
was significantly greater than that of X-CGD cells. Further, after 72-h treatment with 10 mM IP6, CD11b expression
was observed in PLB-985 cells but inhibited in X-CGD cells. Autophagy monitoring after 6-h treatment with 10 mM
IP6 revealed that LC3 expression was suppressed in PLB-985 cells, whereas it was somewhat increased in X-CGD
cells.
Conclusions: Our results suggest that NADPH oxidase activation mediates IP6-induced metabolic disruption
associated with necrosis, differentiation, cell growth, and autophagy in PLB-985 cells.
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Introduction
Reactive oxygen species (ROS) comprise a group of highly
reactive, oxygen-containing compounds. These compounds occur
in living cells and tissues under both physiological conditions
(such as during respiratory metabolism) and pathological
conditions. Several exogenous sources such as carcinogens,
ultraviolet light, and ionizing radiation may induce ROS
formation.1,2 Endogenous ROS are known to play a beneficial role
in host defense, cell signaling, and biosynthetic reactions.1,2 To
maintain homeostasis of redox status, the effects of ROS are
mediated by intrinsic defense mechanisms and dietary
antioxidants such as vitamin C, vitamin E, glutathione, catalase,
myeloperoxidase, and superoxide dismutase.1,3 Impaired regula-
tion may lead to dramatic increases in ROS levels, resulting in
protein damage, membrane peroxidation, and DNA cleavage.4,5
Cell damage that is induced by ROS is believed to be a major
factor in the processes of aging, chronic inflammation,
arteriosclerosis, and carcinogenesis.6,7
Inositol hexaphosphate (IP6, also known as phytic acid) is the
phosphate ester of inositol in which six hydroxyl groups are
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replaced by phosphate.8 This compound was first identified as an
important nutrient and the principal storage form of phosphorus
in many plant tissues, especially bran and seeds.9 Grains and
beans contain approximately 1%–5% IP6 by weight, which is
hydrolyzed and consumed during germination for phosphate
metabolism in plants.10 Mammalian cells and tissues are known
to contain IP6 and its metabolites.11 Endogenous IP6, lower
inositol phosphates, and inositol pyrophosphates have been
shown to be involved in a wide range of biological and
physiological functions such as energy storage, cation transport,
signal transduction, cell proliferation, DNA repair, and mRNA
export.12–15 The strong affinity of IP6 toward metal cations is due
to the presence of the negatively charged phosphate residue,1 and
is crucial for one of the major biological functions of IP6—its role
as an antioxidant, which involves the elimination of free metals
and suppression of metal-induced ROS.16,17 Dietary intake of IP6-
rich and high-fiber ingredients is considered effective against
gastrointestinal oxidative damage, which can lead to inflammation
and cancer.18 Recent studies have investigated the potential
clinical efficacy of IP6 against intestine, breast, and lung can-
cer.19–22 A review of the literature revealed that the metal-binding
properties of IP6 may inhibit dental plaque formation and protect
against renal calculi formation.23,24 In addition, IP6 has been used
as a key material in the production of chelate-setting calcium
biocement.25,26
Nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase, a membrane-bound enzyme complex, catalyzes the
production of the superoxide free radical by transferring one
electron to oxygen from NADPH during the respiratory burst of
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phagosomes. In addition, its isoforms play a catalytic role in
various tissues.27,28 In a previous study, the X-linked chronic
granulomatous disease (X-CGD) cell line was generated by
disrupting the gp91-phox gene, which encodes a heme-binding
membrane glycoprotein of cytochrome b558 of the human
NADPH oxidase, through homologous recombination in the
human leukemia cell line PLB-985.29 Therefore, the X-CGD cell
line provides an excellent cell-based system for investigating the
potential functions of NADPH oxidase and reactive oxygen
intermediates.30 The aim of the present study was to identify the
role of NADPH oxidase activation in IP6-induced metabolic
disruption in leukemia cells.
Methods
Cell culture
The human myelomonoblastic (PLB-985) cell line was
originally obtained from Dr. P. Newburger31; X-CGD cells
prepared from PLB-985 cells through disruption of the X
chromosome–linked gp91-phox gene were kindly gifted from
Dr. S.J. Chanock.29 Cells were maintained in RPMI-1640 medium
(Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented
with 10% fetal bovine serum (FBS) at 37°C in 5% CO2.
Inositol hexaphosphate treatment
Inositol hexaphosphate was purchased from Sigma-Aldrich (St.
Louis, MO, USA). It was directly dissolved in RPMI 1640
medium containing 10% FBS, and the pH adjusted at 7.0 using
1 M NaOH and 1 M HCl to prepare 40 mM IP6 fresh stock
solution. The stock solution was added into the culture medium
in which cells were being cultured, to obtain the final
concentration of IP6.
Cell growth
Cells were incubated with IP6 in non-treated 96-well plates
(5×105 cells/mL) for 24 h. Cell growth was assayed using a
highly water-soluble tetrazolium salt (WST-8)-based proliferation
assay (Dojindo Molecular Technologies Inc., Kumamoto, Japan),
according to the manufacturer’s instructions. Cells were
incubated with WST-8 for 4 h, after which calorimetric analysis
was performed to assess the growth rate. To this end, the
absorbance of WST-8 formazan was determined at 450 nm using
a microplate reader (MTP-301, Hitachi High-Technologies
Corporation, Tokyo, Japan). Cell growth rate was calculated by
dividing the absorbance value of treated cells by the absorbance
value of control cells. This was carried out for each concentration
of IP6 that was tested.
Apoptosis and necrosis
The pattern of cell death was evaluated using an Annexin V-
fluorescein isothiocyanate (FITC)/propidium iodide (PI) assay
(Apoptosis Detection Kit; BioVision Technologies, Inc., PA,
USA). The cells (5×105 cells/mL) were incubated with IP6 in an
untreated flask for 6 or 24 h. After incubation, the stained cells
were collected and analyzed using a Beckman FC500 flow
cytometer (Beckman Coulter, Inc., CA, USA). The dot plot profile
of flow cytometry using FITC and PI was used to discriminate
between apoptotic (FITC+/PI–) and necrotic cells (FITC–/PI+).
CD11b expression
Cell differentiation was assessed by analyzing CD11b (Mac1-α)
—a marker of monocytic property in differentiated PLB-985
cells. Cells were treated with IP6 in a tissue culture-treated flask.
After a 72-h incubation, cells were collected by centrifugation at
1,000 g for 5 min at 4 °C. After two washes with phosphate-
buffered saline (PBS(–)), the cells (1×106) were resuspended in
1.0 mL of PBS(–) containing monoclonal anti-human CD11b
(Mac1-α)-monoclonal antibody FITC conjugate (Sigma-Aldrich).
Following a 30-min incubation at room temperature (RT), the
cells were analyzed using flow cytometry.
Autophagy
To investigate the effects of IP6 on autophagy in PLB-985 and
X-CGD cells, LC3 expression was measured as an autophagy
marker. After a 6-h incubation with IP6, the cells were collected
by centrifugation at 1,000 g for 5 min at 4°C. After two washes
with PBS(–), cells were fixed in 2% paraformaldehyde/PBS(–) for
30 min at RT. Following two washes with PBS(–), the cells were
permeabilized with 100 μg/ml digitonin (Tokyo Chemical Industry
Co., LTD., Tokyo, Japan), for 15 min at RT. After two washes with
PBS(–), the cells were incubated with rabbit anti-human LC3
polyclonal antibody (MBL; Medical & Biological Laboratories
Co., Ltd., Nagoya, Japan) for 30 min at RT. Then, cells were
washed with PBS(–) and incubated with a secondary donkey anti-
rabbit IgG (H+L chain) polyclonal antibody FITC (MBL) for
15 min at RT in dark. After washing with PBS(–), cells were
analyzed using a flow cytometer. The X-mean (average value for
events in the population) was calculated using Beckman Software
CXP version 2.2.
Statistical analysis
Statistical analyses were performed on triplicate data using the
unpaired Student’s t-test, and data are presented as standard
deviation values of the mean. Statistical significance was
accepted at P<0.05.
Results
Effect of inositol hexaphosphate on cell growth
Figure 1 shows the effect of IP6 treatment on cell growth. The
growth of both cell lines was suppressed following treatment
with 5 or 10 mM IP6, although this suppression was more
Figure 1 Effect of inositol hexaphosphate on the growth of PLB-985
and X chromosome linked gp91-phox gene knockout cells.
Cells were incubated with inositol hexaphosphate for 24 h. Cell growth
rate was assayed using a highly water-soluble tetrazolium salt, WST-8.
Mean (±standard deviation) values from three independent experiments
are presented. *P<0.05 (Student’s t-test).
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dramatic in PLB-985 cells. Following treatment with 20 mM IP6,
no cell growth was observed in either cell line.
Inositol hexaphosphate-induced cell death
Figure 2 illustrates the rates of apoptotic and necrotic cell
death determined using Annexin V-FITC/PI and flow cytometry.
No apoptotic cell death of PLB-985 or X-CGD cells was observed
following treatment with IP6 for 6 or 24 h. However, IP6 induced
necrotic cell death in both cell lines. After 6-h treatment with
20 mM IP6, the rate of necrotic cell death of PLB-985 cells was
significantly greater than that of X-CGD cells.
Inositol hexaphosphate-induced differentiation
Incubation of PLB-985 cells with IP6 for 72 h caused changes
in their adhesive properties, and the cells exhibited potential
attachment to the culture flask. After a 72-h incubation with IP6,
PLB-985 and X-CGD cells were trypsinized and incubated with
anti-CD11b FITC. Figure 3 presents the flow-cytometric
Figure 2 Inositol hexaphosphate -induced cell death
Inositol hexaphosphate (IP6)-treated cells were analyzed with flow cytometry using Annexin V-Fluorescein isothiocyanate (FITC)/propidium iodide (PI).
A) Typical flow cytometry pattern of IP6-treated cells using the dot plot with Annexin V-FITC on the X-axis versus PI on the Y-axis. B) rate of apoptotic
and necrotic cell death obtained from three independent experiments. *P<0.05 (Student’s t-test).
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Figure 3 Results of flow cytometry showing inositol hexaphosphate-
induced CD11b expression
In A) PLB-985 and B) X chromosome linked gp91-phox gene knockout
cells following incubation with 0 mM (solid line), 5 mM (broken line), and
10 mM (dotted line) inositol hexaphosphate for 72 h. Each histogram
shows the CD11b level (measured as signal intensity of antibody
fluorescein isothiocyanate) on the X-axis versus cell count on the Y-axis.
histograms of FITC intensity of the cells. After treatment with
10 mM IP6, two peaks were observed in the histogram obtained
from flow cytometry of X-CGD cells. This indicates that IP6-
induced CD11b expression was suppressed in X-CGD cells.
Effects of inositol hexaphosphate on autophagy
The histogram of LC3-FITC in log-phase control cells (prior to
IP6 treatment) showed a double peak profile for both cell lines
(Figure 4A, a and c). After 6 h of treatment with 10 mM IP6,
double peaks were still observed in the histogram of LC3-FITC
for PLB-985 cells; however, the intensity of the signal of the
main peak was considerably decreased (Figure 4A, b).
Nevertheless, the histogram of IP6-treated X-CGD cells showed
a single peak, indicating increased LC3 expression (Figure 4A, d).
The average value (X-mean) of LC3 calculated from flow
cytometry revealed a significant difference between PLB-985 and
X-CGD cells (Figure 4B). Our results suggested that the
suppression of the bulk degradation system of autophagy resulted
in growth inhibition and differentiation in PLB-985 cells.
Figure 4 Detection of LC3 levels with flow cytometer
A) Typical flow cytometry histogram of cells treated with 10 mM inositol hexaphosphate. Each histogram shows the LC3 levels (measured as signal
intensity of the secondary antibody IgG-fluorescein isothiocyanate) on the X-axis versus cell count on the Y-axis. B) The average value (X-mean) of LC3
level calculated from the flow cytometry of the cells treated with 5 and 10 mM inositol hexaphosphate for 6 h obtained from three independent
experiments. *P<0.05 (Student’s t-test).
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Discussion
Understanding the mechanisms that underly IP6-induced
biological effects is fundamental to the clinical application of the
compound. One of the major benefits of IP6 is its antioxidant
effect.17 Grases et al. reported the IP6 level in plasma to be
0.26±0.03 mg/L in human volunteers who followed a diet that
included normal levels of IP6.32 Dietary IP6 is believed to protect
against intestinal cancer and inflammation.14 Norhaizan et al.
reported that IP6 caused inhibition of cell growth in ovary, breast,
and liver cancer cells with 50% maximal inhibitory concentration
(IC50) values of 3.45, 3.78, and 1.66 mM, respectively.22 However,
the fact that IP6 ameliorates oxidative stress in biological tissues
does not adequately explain the mechanism of IP6-induced cell
death. Recent studies investigating the potential mechanisms of
IP6-induced biological disorder have suggested that IP6 is
associated with the AKT/mTOR signaling pathway, p53 function,
NF-kappaB, and the BCL-2 family.33–36 The suppression of IP6-
induced apoptotic processes through disruption of p53 function in
PLB-985 cells, which are p53 null, is considered to be a reason
for the low cytotoxicity of IP6 toward PLB-985 cells.30
We hypothesized that NADPH oxidase is one of the key
components of IP6-induced metabolic disruption. Our experiment
involving IP6 treatment of X-CGD cells indicated that cell
growth, cell death, differentiation, and autophagy were influenced
by knockout of the gp91-phox gene. Free IP6 in extracellular fluid
functions as an antioxidant through its metal-chelating
properties. However, metal-binding IP6 that is incorporated in
the phagosome may play a role in amplification of ROS generated
by NADPH oxidase. In phagocytes, NADPH oxidase is referred
to as NOX2, a homolog of the NOX family that is found in several
tissues.28 It is widely accepted that ROS generated by members
of the NOX family play important roles in a wide range of signal
transduction pathways. Our results suggest a novel role of the
NOX family as mediators of the biological effects of IP6.
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